Clinical Pharmacology · Thyroid and Adrenal Medications
Corticosteroids
On this page 6 sections
In 30 seconds
Systemic corticosteroids (hydrocortisone, prednisone, prednisolone, methylprednisolone, dexamethasone) are synthetic versions of cortisol used to shut down inflammation and immune activity across an enormous range of diseases. They work by entering cells and reprogramming gene transcription, which is why effects build over hours rather than seconds. Their power comes with a cost: prolonged use suppresses the body's own adrenal function and produces predictable effects on metabolism, bone, skin, mood, and infection risk, so tapering and monitoring are as important as the drug itself.
The college version
The HPA Axis and Endogenous Cortisol
The hypothalamic-pituitary-adrenal (HPA) axis is the body's stress-and-metabolism regulatory loop. The hypothalamus releases corticotropin-releasing hormone (CRH), prompting the anterior pituitary to secrete adrenocorticotropic hormone (ACTH), which stimulates the adrenal cortex to produce cortisol. Cortisol feeds back to suppress CRH and ACTH, keeping the loop in balance. Cortisol secretion follows a diurnal rhythm: it peaks in the early morning to support alertness and energy mobilization and falls to its lowest point around midnight. Cortisol is a glucocorticoid with mild mineralocorticoid activity, meaning it also promotes some sodium retention and potassium loss, though far less than aldosterone. This natural rhythm is why exogenous corticosteroid dosing is typically timed to mimic morning secretion.
Mechanism of Action
Synthetic corticosteroids are lipophilic and diffuse across the cell membrane to bind cytoplasmic glucocorticoid receptors. The hormone-receptor complex moves into the nucleus, binds DNA response elements, and alters transcription in two directions. It suppresses genes for pro-inflammatory cytokines, prostaglandins, and adhesion molecules by inhibiting the transcription factors that drive the inflammatory cascade, and it induces genes for anti-inflammatory proteins, including one that blocks the enzyme releasing arachidonic acid, the precursor of inflammatory prostaglandins and leukotrienes. Because this works through gene expression rather than a fast receptor-channel action, effects take time to develop and to wear off, distinguishing corticosteroids from drugs with immediate onset.
Agents, Potency, and Duration
Corticosteroids differ in relative glucocorticoid potency, mineralocorticoid activity, and duration of action, which guides how each is chosen.
- Hydrocortisone is closest to endogenous cortisol: lowest glucocorticoid potency of the group but meaningful mineralocorticoid activity, short duration. Favored for physiologic adrenal replacement and stress dosing.
- Prednisone is a prodrug converted by the liver to prednisolone, its active form; both have intermediate potency, reduced mineralocorticoid activity versus hydrocortisone, and intermediate duration. A mainstay for many inflammatory and autoimmune conditions.
- Prednisolone is used directly when hepatic conversion is a concern, such as significant liver impairment, since it needs no activation.
- Methylprednisolone has somewhat greater glucocorticoid potency with minimal mineralocorticoid activity and intermediate duration; commonly given intravenously for acute flares or transplant settings.
- Dexamethasone has the highest glucocorticoid potency here, essentially no mineralocorticoid activity, and the longest duration, useful for cerebral edema, certain oncologic protocols, and situations where mineralocorticoid effects should be minimized. As glucocorticoid potency rises, mineralocorticoid activity generally falls and duration tends to lengthen — a pattern worth understanding conceptually rather than memorizing as numbers.
Clinical Uses
The breadth of indications reflects the reach of the anti-inflammatory and immunosuppressive mechanism: inflammatory conditions such as asthma exacerbations, COPD flares, and inflammatory bowel disease; autoimmune diseases such as lupus, rheumatoid arthritis, and vasculitis; allergic reactions including severe hypersensitivity and anaphylaxis adjuncts; oncologic regimens where corticosteroids reduce tumor-associated edema, treat certain hematologic malignancies, and control chemotherapy-induced nausea; transplant medicine, preventing and treating organ rejection; and endocrine replacement in adrenal insufficiency, where the goal is restoring physiologic cortisol rather than suppressing an overactive process.
Adverse Effects by System
Metabolic effects include hyperglycemia (from increased gluconeogenesis and insulin resistance), weight gain, and a cushingoid pattern of fat redistribution to the face, upper back, and trunk with limb sparing. Cardiovascular and fluid effects include hypertension, fluid retention, and hypokalemia from mineralocorticoid crossover. Musculoskeletal effects include osteoporosis and fracture risk from reduced bone formation and calcium absorption, avascular necrosis of large joints such as the hip, and proximal muscle myopathy. Dermatologic effects include thin, fragile skin, easy bruising, and poor wound healing from impaired collagen synthesis. Ocular effects include cataracts and elevated intraocular pressure that can progress to glaucoma. Gastrointestinal risk includes peptic ulcer formation, which rises sharply when combined with NSAIDs. Neuropsychiatric effects range from insomnia and mood lability to euphoria, anxiety, and, at the severe end, frank psychosis. In children, growth suppression can occur with sustained use. Across all systems, corticosteroids blunt the immune response and the inflammatory signs (fever, pain, swelling) that normally reveal infection, so a serious infection can present deceptively mildly. Effects generally track with intensity and duration of therapy: short courses carry mainly metabolic and gastrointestinal risk, while sustained therapy adds bone, ocular, skin, and endocrine suppression risks.
HPA Axis Suppression, Tapering, and Adrenal Crisis
Exogenous corticosteroids suppress CRH and ACTH through the same feedback loop that regulates natural cortisol, causing the adrenal cortex to atrophy from disuse. If therapy has continued long enough to suppress the axis and is stopped abruptly, the adrenals cannot respond quickly enough to sudden demand for cortisol, risking adrenal crisis: profound hypotension, shock, severe weakness, abdominal pain, vomiting, and altered mental status, a medical emergency. This is why longer courses are tapered gradually rather than stopped outright, giving the HPA axis time to recover its own output. During physiologic stress such as acute illness, surgery, or trauma, patients on chronic corticosteroid therapy need temporarily increased ("stress") dosing to cover demand their suppressed axis cannot meet alone.
Monitoring and Patient Teaching
Monitoring includes blood glucose (especially in diabetic or at-risk patients), blood pressure, bone density over long-term therapy, and periodic eye exams for cataracts and intraocular pressure. Patient teaching centers on taking oral doses with food to reduce gastrointestinal irritation, dosing in the morning to mirror the natural cortisol rhythm and limit sleep disruption, wearing medical alert identification noting corticosteroid dependence, and never skipping or abruptly stopping doses without medical guidance given the tapering and adrenal-suppression concerns above.

Eli explains
The same idea, in plain words
Explain it like I’m 10
Think of cortisol as your body's built-in alarm-and-energy hormone, made by two little glands atop your kidneys, following orders from your brain like a chain of command: brain sends a signal, a middle station relays it, the glands respond. It's naturally loudest in the morning to help you wake up and get going, and quiet at night.
Corticosteroid medicines are copies of that alarm hormone doctors give to calm inflammation, like turning down a fire alarm that won't stop ringing even after the smoke is gone. But if you take the copy for a long time, your own glands sense "someone else is handling the alarm" and get lazy, shrinking a little. That's fine while you're still taking the medicine, but if you suddenly stop, your glands can't wake back up fast enough, and that's dangerous, like shutting off a factory without warning the workers to power down the machines properly. So doctors turn the dose down slowly, step by step, a taper, and give extra medicine during things like surgery or a bad illness, when the body needs extra "alarm hormone" the sleepy glands can't supply.
Check yourself
2 review questions from the chapter. Try each one, then open the answer.
A patient who has been on daily oral corticosteroid therapy for an extended period is scheduled for major surgery next week. What should the care team anticipate regarding this patient's corticosteroid dosing around the time of surgery, and why?
Show answer
Expect temporary "stress dosing," meaning extra corticosteroid coverage around the time of surgery
The patient's own adrenal glands have gotten used to not working as hard because the medicine has been doing their job, so during the extra physical stress of surgery they can't ramp up cortisol on their own the way a healthy person's would. A boosted dose around the procedure covers that gap until the stress passes.
A patient on long-term corticosteroid therapy decides on his own to stop taking his pills abruptly because he feels better. What clinical picture should raise concern in the days that follow, and what is the underlying physiological reason?
Show answer
Watch for adrenal crisis, showing up as severe low blood pressure, weakness, nausea or vomiting, and confusion, in the days after stopping
Because his own glands shrank a little from not being used while the medicine covered for them, they can't suddenly supply the cortisol his body needs the moment the pills stop, leaving him dangerously short on a hormone essential for handling everyday stress. This is exactly why doses are tapered down slowly instead of stopped all at once.
Quick check
3 questions here. Answers stay hidden until you check.
A patient taking a corticosteroid for an inflammatory bowel condition asks why the drug takes hours to relieve her symptoms rather than working immediately. What is the best explanation?
Which combination of findings in a patient on long-term corticosteroid therapy best reflects the classic cushingoid pattern?
Study tools & related lessonsRelated
Educational content only. It is not medical, legal or professional advice. Found an error? Tell us.

